Oral selective estrogen receptor degraders for metastatic hormone receptor-positive, HER2 negative breast cancer according to ESR1 mutation: A systematic review and meta-analysis of randomized control trials

Category Systematic review
JournalESMO Open
Year 2023
This article has no abstract
Epistemonikos ID: 5597aa735b31fbef2f8364872b250bb4e11baeab
First added on: Feb 16, 2025